0001724287-18-000002.txt : 20180223 0001724287-18-000002.hdr.sgml : 20180223 20180223105024 ACCESSION NUMBER: 0001724287-18-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20180223 DATE AS OF CHANGE: 20180223 EFFECTIVENESS DATE: 20180223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bridge Therapeutics, Inc. CENTRAL INDEX KEY: 0001724287 IRS NUMBER: 473513057 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-306250 FILM NUMBER: 18635126 BUSINESS ADDRESS: STREET 1: 1160 HUFFMAN ROAD STREET 2: ATTN: DR. G. SULLIVAN CITY: BIRMINGHAM STATE: AL ZIP: 35215 BUSINESS PHONE: 251-401-1187 MAIL ADDRESS: STREET 1: 1160 HUFFMAN ROAD STREET 2: ATTN: DR. G. SULLIVAN CITY: BIRMINGHAM STATE: AL ZIP: 35215 D/A 1 primary_doc.xml X0708 D/A LIVE 0001724287 Bridge Therapeutics, Inc. 1160 HUFFMAN ROAD ATTN: DR. G. SULLIVAN BIRMINGHAM AL ALABAMA 35215 251-401-1187 DELAWARE None None Corporation true 2016 Kelley S Alton 1160 Huffman Rd. Birmingham AL ALABAMA 36608 Executive Officer Joseph Mullin 1160 Huffman Rd. Birmingham AL ALABAMA 36608 Executive Officer Director David H Bergstrom 1160 Huffman Rd. Birmingham AL ALABAMA 36608 Director Diana Harshbarger 1160 Huffman Rd. Birmingham AL ALABAMA 36608 Director James G Sullivan 1160 Huffman Rd. Birmingham AL ALABAMA 36608 Executive Officer Director Elizabeth Kelley 1160 Huffman Rd. Birmingham AL ALABAMA 36608 Director Pharmaceuticals Decline to Disclose 06c true 0001724287-18-000001 true false true true true Convertible Note and/or Equity false 50000 VENOVATE MARKETPLACE, INC. 151143 None None 1953 San Elijo Avenue Suite 203 Cardiff CA CALIFORNIA 92007 CA CALIFORNIA CT CONNECTICUT DC DISTRICT OF COLUMBIA FL FLORIDA IL ILLINOIS MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA TX TEXAS false Indefinite 0 Indefinite false 0 0 true 0 0 false Bridge Therapeutics, Inc. Luke S Richbourg Luke S Richbourg Attorney-in-Fact 2018-02-23